Inflammation Protocol: Root Cause Resolution

Understanding Chronic Inflammation

Chronic systemic inflammation is the root mechanism of most modern disease: cardiovascular disease, metabolic dysfunction, autoimmune conditions, cognitive decline, and accelerated aging. Unlike acute inflammation (the helpful immune response to injury or infection), chronic inflammation represents dysregulated immune signaling where inflammatory cytokines remain perpetually elevated. This low-grade inflammation burns tissues slowly, accelerates aging, and impairs virtually every physiological system.

The sources of chronic inflammation are multifactorial: dietary factors (seed oils, refined carbohydrates, processed foods), dysbiosis (gut bacterial imbalance), sleep deprivation, stress, and persistent metabolic dysfunction. Rather than address symptoms, effective inflammation resolution addresses root causes. Research by immunologist Dr. Charles Serhan demonstrates that systematic intervention targeting inflammation resolution (not just suppression) can normalize inflammatory markers and restore immune homeostasis within 8-12 weeks in most individuals.

Critical distinction: suppression (antiinflammatories like NSAIDs) temporarily reduces inflammatory symptoms but allows the underlying dysregulation to persist. Resolution actively signals the body to terminate inflammation, clear inflammatory cells, and restore normal immune function. This protocol focuses on resolution rather than suppression, enabling lasting normalization of inflammatory status.

Inflammation Biomarkers and Testing

Measuring inflammation is essential for protocol effectiveness assessment. High-sensitivity C-reactive protein (hs-CRP) is the primary marker. Values below 1 mg/L indicate low inflammation; values above 3 mg/L indicate substantial chronic inflammation. Interleukin-6 (IL-6) is another critical marker - it drives much of the downstream inflammatory cascade. Values above 2-3 pg/mL suggest significant systemic inflammation.

Before starting the protocol, establish baseline biomarkers: hs-CRP and IL-6. Retest at 4-8 weeks to assess protocol progress. Most individuals see meaningful improvement (25-50 percent reduction) within 4-8 weeks; substantial improvement (70-90 percent reduction toward normal ranges) within 8-12 weeks. Biomarker tracking motivates compliance and demonstrates whether the protocol approach is working for that individual.

Additional markers to consider: TNF-alpha (tumor necrosis factor-alpha), which drives inflammatory pain and joint inflammation; homocysteine, which contributes to vascular inflammation; complete metabolic panel to assess metabolic dysfunction; and omega-3 index (ratio of EPA+DHA to arachidonic acid in red blood cells), which predicts cardiovascular risk and inflammation status. Some individuals also benefit from food-specific antibody testing (IgG) to identify food sensitivities contributing to inflammation.

Omega-3 Foundation: EPA/DHA Ratios

Omega-3 fatty acids (particularly EPA and DHA) are anti-inflammatory; omega-6 fatty acids (particularly arachidonic acid) are pro-inflammatory. Western diets are dramatically omega-6 dominant (ratios of 10-20:1 omega-6 to omega-3), driving chronic inflammation. Optimal ratios are closer to 2-4:1. Correcting this imbalance is foundational to inflammation resolution.

EPA is more potently anti-inflammatory than DHA. Research by immunologist Dr. Philip Calder documents that EPA supplementation reduces inflammatory cytokines including TNF-alpha and IL-6 by 20-30 percent within 4-8 weeks. The effect is dose-dependent; higher EPA doses produce greater anti-inflammatory effects. Combined with DHA for brain and cardiovascular support, EPA/DHA supplementation forms the foundation of the anti-inflammatory protocol.

Dosage: Use high-EPA omega-3 fish oil or algae-based products providing 2-4 grams daily of combined EPA+DHA, with EPA comprising at least 60 percent of the total (meaning 1.2-2.4 grams EPA daily). Higher doses (up to 8 grams daily) are used in research protocols investigating aggressive inflammatory reduction. Take with meals containing fat for optimal absorption. Plan for 4-8 weeks of supplementation to produce maximal inflammatory reduction.

Quality matters critically - choose molecularly distilled fish oil (removed contaminants including mercury) or reputable algae-based versions. Test omega-3 index if available; optimal index is above 8 percent (EPA+DHA comprising more than 8 percent of red blood cell membrane fatty acids). Most Western individuals start with omega-3 index below 4 percent; supplementation raises this substantially within 8-12 weeks.

Curcumin with Piperine

Curcumin, the active compound in turmeric, is one of the most extensively researched anti-inflammatory compounds. It inhibits NF-kappa B, a master regulator of inflammatory gene expression, reducing production of TNF-alpha, IL-6, and other inflammatory cytokines. Research documents curcumin reduces inflammatory markers by 25-40 percent within 4-8 weeks, with effects particularly pronounced when combined with EPA/DHA.

The challenge with curcumin is absorption - it's fat-soluble but poorly bioavailable. Piperine (black pepper alkaloid) increases curcumin absorption by 2000 percent. Curcumin plus piperine produces dramatically greater anti-inflammatory effects than curcumin alone. Choose products standardized to 95+ percent curcuminoids with added piperine, or use a combination providing transparent dosing of both components.

Dosage: Use curcumin extract standardized to 95+ percent curcuminoids with piperine at 500-1000mg curcumin daily, divided into 2-3 doses taken with meals containing fat. Some protocols use higher doses up to 2000mg daily in divided doses; evidence for superiority beyond 1000mg daily is limited. Curcumin requires 4-8 weeks of consistent use to produce maximal inflammatory reduction. Take without interruption.

Curcumin is well-tolerated. Occasional mild gastrointestinal effects (heartburn, loose stools) resolve with dose reduction or consistent use. Curcumin has mild blood-thinning properties (beneficial for cardiovascular health, not problematic) so avoid combining with blood thinner medications without medical guidance. Curcumin shows synergistic anti-inflammatory effects when combined with EPA/DHA, making the combination more potent than either alone.

Specialized Pro-Resolving Mediators (SPMs)

Specialized pro-resolving mediators are endogenous lipid mediators that actively signal the body to terminate inflammation and clear inflammatory debris. Unlike anti-inflammatory compounds that suppress inflammation, SPMs actively resolve it by promoting inflammatory cell clearance, enhancing tissue repair, and restoring homeostasis. Research by Dr. Serhan demonstrates that SPM deficiency is a primary mechanism of chronic inflammation; correcting SPM levels enables rapid inflammatory resolution.

The body produces SPMs from EPA and DHA through enzymatic conversion. Adequate fish oil consumption should theoretically provide sufficient SPM substrate, but many individuals have impaired enzymatic conversion due to dysbiosis, genetic factors, or chronic disease. SPM supplementation directly provides these mediators, enabling rapid resolution even in individuals with impaired endogenous production.

Dosage: Use standardized SPM products providing lipoxins, resolvins, and protectins at 150-500mg daily (amounts vary by product formulation). Most research uses 300-400mg daily. Take with meals containing fat. SPM supplementation produces faster inflammatory reduction than EPA/DHA alone, with noticeable improvement within 1-2 weeks in many individuals. SPMs work synergistically with EPA/DHA - the combination produces superior inflammatory resolution compared to either component alone.

SPM supplementation is exceptionally safe with no documented side effects. Quality varies among manufacturers - choose established companies with transparent ingredient declarations. SPMs are heat-sensitive; store in cool, dark places and avoid exposing supplements to heat or light.

N-Acetylcysteine (NAC)

NAC is a precursor for glutathione, the body's primary antioxidant and anti-inflammatory molecule. Chronically inflamed individuals have depleted glutathione; supplementing NAC restores glutathione production, reducing oxidative stress and inflammation. Research documents that NAC supplementation reduces TNF-alpha by 15-25 percent, reduces IL-6 by 10-20 percent, and provides mucosal and immune support.

NAC also supports detoxification through glutathione-dependent pathways, helping clear inflammatory toxins and endotoxins that perpetuate inflammation. This secondary mechanism addresses root causes of inflammation rather than just suppressing the symptoms. Combined with omega-3s and curcumin, NAC provides comprehensive inflammatory reduction through multiple mechanisms.

Dosage: Use NAC at 600-1200mg daily, divided into 2-3 doses taken with meals. Most protocols use 1000mg daily. NAC requires 2-4 weeks of consistent use to produce maximal glutathione restoration and inflammatory reduction. Take with adequate vitamin C and B vitamins to optimize glutathione synthesis. NAC works synergistically with the other protocol components, particularly omega-3s and SPMs.

NAC is well-tolerated. Occasional mild sulfur-like body odor (due to NAC's sulfur content) resolves with dose reduction or consistent use. NAC has anticoagulant properties (beneficial for cardiovascular health) so avoid combining with blood thinners without medical guidance. Store in cool, dry places as NAC degrades with heat and moisture exposure.

Quercetin: Bioflavonoid Support

Quercetin is a plant bioflavonoid with anti-inflammatory and antihistamine properties. It inhibits mast cells (immune cells that release inflammatory mediators), reduces inflammatory cytokine production, and provides antioxidant support. Research documents that quercetin supplementation reduces inflammatory markers by 15-25 percent and is particularly effective for individuals with high histamine or allergic components to their inflammation.

Quercetin is naturally abundant in apples, onions, and other plant foods but usually in insufficient amounts for therapeutic anti-inflammatory effect. Supplementation provides therapeutic doses. Quercetin shows synergistic effects with NAC and vitamin C - the combination produces greater anti-inflammatory benefit than quercetin alone.

Dosage: Use quercetin at 500-1000mg daily, divided into 2 doses taken with meals. Some protocols use higher doses up to 2000mg daily; evidence for superiority beyond 1000mg is limited. Quercetin works best when combined with vitamin C (which enhances absorption and bioflavonoid effectiveness) and NAC. Take consistently for 4-8 weeks to produce maximal effects.

Quercetin is well-tolerated. It's a dietary compound with excellent safety profile. Quercetin enhances absorption of iron (beneficial for iron-deficient individuals, potentially problematic for iron-overload conditions) - monitor accordingly. Quercetin synergizes with the entire inflammation protocol, particularly with NAC and vitamin C supplementation.

Fasting Protocols for Inflammation

Intermittent fasting and periodic fasting are potent anti-inflammatory interventions. Fasting triggers autophagy (cellular self-cleaning) which removes inflammatory cells and damaged tissues. Research documents that even mild fasting (extending the overnight fast to 14-16 hours daily) reduces inflammatory markers by 10-20 percent within 2-4 weeks. More extended fasting (24-36 hours once weekly or periodically) produces greater anti-inflammatory effects.

Fasting is particularly effective for addressing metabolic dysfunction - excess body weight, particularly visceral fat, drives chronic inflammation. Fasting addresses this root cause by promoting fat loss while simultaneously providing anti-inflammatory benefits independent of weight loss. The combination of fasting plus supplementation produces far superior inflammatory reduction than supplementation alone.

Protocol: implement intermittent fasting with 14-16 hour daily fasting windows (for example, stop eating by 8pm, begin eating at 10am). This mild fasting is compatible with most lifestyles and produces meaningful anti-inflammatory effects. Additionally, perform one 24-hour fast monthly (fasting from dinner one day to dinner the next day) for more substantial inflammatory reduction. Extend fasting duration gradually - aggressive fasting introduced abruptly can cause symptoms.

Critical factors: adequate hydration during fasts; adequate food intake during eating windows (don't restrict calories on eating days); continued supplementation through fasting periods (most supplements can be taken with water); and listening to individual tolerance (some individuals experience dysphoria or excessive fatigue with extended fasting - shorter fasts work better for these individuals). Fasting combines with all other protocol components for maximal anti-inflammatory effect.

Dietary Elimination and Triggers

Dietary factors perpetuate or even cause chronic inflammation. Standard inflammatory triggers include: seed oils (soy, corn, canola - high omega-6 content), refined carbohydrates (promote dysbiosis and metabolic dysfunction), processed foods (contain additives that trigger immune responses), and foods that individual tolerates poorly (highly variable, but commonly wheat, dairy, or other specific foods).

Additionally, dysbiosis (gut bacterial imbalance) perpetuates inflammation through leaky gut and bacterial endotoxin translocation. Addressing dysbiosis through dietary elimination, prebiotic intake (soluble fiber), and potentially probiotic supplementation accelerates inflammatory resolution. Replace seed oils with olive oil, coconut oil, and avocado oil. Prioritize whole foods, particularly those rich in fiber and polyphenols (colorful vegetables, berries, herbs).

Testing: if available, perform IgG food-sensitivity testing to identify individual trigger foods; eliminate identified triggers. If testing unavailable, perform systematic elimination and reintroduction: eliminate suspected trigger foods (wheat, dairy, eggs, nightshades) for 4 weeks, then systematically reintroduce them individually while monitoring for symptom recurrence. Many individuals notice substantial anti-inflammatory improvement through dietary changes alone.

Implementation Timeline

Week 1: Establish baseline biomarkers (hs-CRP, IL-6 if available), implement dietary modifications (eliminate seed oils, refined carbohydrates, processed foods), begin intermittent fasting (14-16 hour daily fasts). Start high-EPA omega-3 supplementation (2-3 grams EPA+DHA daily).

Week 2-3: Maintain dietary modifications and fasting. Add curcumin with piperine (500-1000mg daily), NAC (1000mg daily), quercetin (500-1000mg daily). Start SPM supplementation (300-400mg daily).

Week 4-8: Continue all components. Assess symptoms, energy, pain levels, and subjective inflammatory status. Many individuals notice substantial improvement by week 4-6. Biomarker testing (optional but recommended) at week 4-8 should show 25-50 percent reduction in hs-CRP and IL-6.

Week 8-12: Continue the full protocol. Perform one 24-hour monthly fast in addition to daily intermittent fasting. Reassess biomarkers at week 12 - most individuals show 70-90 percent reduction toward normal ranges. After 12 weeks, you can assess whether to continue current dosing, moderate (use maintenance doses), or adjust based on inflammatory status.

The Bottom Line

Chronic inflammation is addressable through systematic protocols targeting resolution rather than suppression. The combination of omega-3 optimization (2-4 grams EPA+DHA daily), curcumin with piperine (500-1000mg), SPMs (300-400mg), NAC (1000mg), quercetin (500-1000mg), intermittent fasting (14-16 hours daily), and dietary elimination of inflammatory triggers addresses the multifactorial roots of chronic inflammation.

Research by Dr. Serhan and immunologists demonstrates that this approach produces rapid normalization of inflammatory markers - most individuals see 70-90 percent reduction in hs-CRP and IL-6 within 8-12 weeks. The protocol works through multiple mechanisms: direct anti-inflammatory compound action, resolution signaling (SPMs), antioxidant support (NAC, quercetin), metabolic improvement (fasting, dietary changes), and root cause elimination (dysbiosis resolution through diet).

Success requires consistency across all components. Biomarker testing before and after provides objective evidence of protocol effectiveness and motivates compliance. Most individuals notice meaningful subjective improvement (reduced pain, improved energy, better sleep, improved digestion) within 2-4 weeks, with dramatic improvements by week 8-12. The investment in this protocol is modest compared to the benefit of resolved inflammation and restored health.